Jefferies continues buying Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE:LYLY) is one of the Good stocks to buy now. On March 20, Jefferies reiterated a Buy rating on Eli Lilly and Company (NYSE:LLY) with a $1,300 price target. ​The rating is based on the company’s prescribing data for GLP-1 drugs. Oral Wegovy had approximately 89,300 IMS prescriptions and 76,800 Symphony…